Počet záznamov: 1
cyproterónacetát
SYS d017373 LBL 00000nz--a2200000o--4500 005 20250606213402.3 008 920513|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D04.210.500.745.432.219.150 065 $a D04.210.500.883.419.150 066 $a 01 $c 03 150 $a cyproterónacetát $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000726 $Y Androgen Antagonists $w P $a antagonisty androgénu 550 $7 sllk_us_auth*d000970 $Y Antineoplastic Agents $w P $a antineoplastiká 550 $7 sllk_us_auth*d003272 $Y Contraceptive Agents, Male $w P $a kontraceptíva pre mužov 665 $a 93; was CYPROTERONE ACETATE (NM) 1980-92 $2 eng 665 $a Cyproterone/analogs & derivatives (1980-1992) $2 eng 680 9-
$i An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites. $2 eng 750 -2
$a Cyproterone Acetate $2 eng 980 $x M
Počet záznamov: 1